The Proteomics Shared Resource offers state-of-the-art, user-friendly mass spectrometry-based resources to support Cancer Institute members. In addition to providing facilities and services, the Shared Resource enables education, methods development and new applications, designed to meet the rapidly evolving needs of cancer researchers. The Shared Resource operates under the direction of Dr. Allis Chien, with oversight by an interdisciplinary faculty advisory committee. It currently occupies 2200 sq ft of space in a convenient, accessible central campus location, and employs six staff scientists in addition to Dr. Chien. The Shared Resource houses 14 mass spectrometers and associated instrumentation; these include single quadrupole, ion trap, triple quadrupole, Q-TOF and Orbitrap mass spectrometers, with appropriate chromatography front ends. In-house proteomics data processing capabilities include Proteome Discoverer, Mascot, Scaffold, Byonic, Skyline, PEAKS and MaxQuant. Annual operating costs are $1.2M. The facility operates on a cost-recovery basis, with ongoing expenses recovered primarily through user fees. Since 2009, over 80 SCI members have used the Shared Resource. Future goals include the implementation of newly installed MS instrumentation, expansion of protein network analysis and quantitative proteomics services, and enhancement of bioinformatics capabilities. Services provided include: peptide and protein identification, characterization of post-translational modifications, protein quantitation, biomarker verification and metabolic studies. In addition, the Proteomics Shared Resource seeks to educate the Stanford research community on how their research can be enhanced and improved by MS methods. With the availability of quality on campus mass spectrometry support, researchers become more involved with experimental design, data analysis, and results interpretation, developing a real understanding of the MS results. Close proximity between the facility and campus research laboratories promotes interactions between researchers and the Proteomics team. These interactions are mutually beneficial and can lead to new paths of research investigation. Stanford researchers have come to expect and value this type of support from the Shared Resource; Cancer Institute members use this Shared Resource frequently, with half of all usage in FY2014 from members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-13
Application #
9936142
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Banerjee, Imon; Gensheimer, Michael Francis; Wood, Douglas J et al. (2018) Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Sci Rep 8:10037
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15

Showing the most recent 10 out of 322 publications